TREACE MEDICAL CONCEPTS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

TREACE MEDICAL CONCEPTS, INC. reported Cash And Cash Equivalents At Carrying Value of $10.71 million for the year ending 2025.

  • TREACE MEDICAL CONCEPTS, INC. showed a decrease of -5.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from TREACE MEDICAL CONCEPTS, INC.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), TREACE MEDICAL CONCEPTS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 734.0%.
  • Historical annual values: Fiscal year 2025: $10.71 million | Fiscal year 2024: $11.35 million | Fiscal year 2023: $12.98 million | Fiscal year 2022: $19.47 million | Fiscal year 2021: $105.83 million | Fiscal year 2020: $18.08 million | Fiscal year 2019: $12.14 million | Fiscal year 2018: $1.28 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: